Search Results - "Culos, Kathryn"

Maintenance Strategies After Hematopoietic Cell Transplantation by Culos, Kathryn A., Gatwood, Katie S., Byrne, Michael

“…Hematopoietic cell transplantation (HCT) is an essential component of potentially curative therapy for patients with hematologic malignancies. High‐dose…”
Get full text

Novel Targets in the Treatment of Advanced Melanoma: New First-Line Treatment Options by Culos, Kathryn A, Cuellar, Sandra

“…OBJECTIVE To discuss the clinical efficacy and safety of ipilimumab, vemurafenib, and investigational agents for the treatment of unresectable stage III and…”
Get full text

Risk factors associated with early viral reactivation following haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: a pilot study by Baskett, Jordan, Culos, Kathryn A., Satyanarayana, Gowri, Patel, Dilan, Engelhardt, Brian, Savani, Bipin, Jagasia, Madan, Kassim, Adetola A., Gatwood, Katie S.

Get full text

Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide Plus Thiotepa Improves Donor Engraftment in Patients with Sickle Cell Anemia: Results of an International Learning Collaborative by de la Fuente, Josu, Dhedin, Nathalie, Koyama, Tatsuki, Bernaudin, Francoise, Kuentz, Mathieu, Karnik, Leena, Socié, Gérard, Culos, Kathryn A., Brodsky, Robert A., DeBaun, Michael R., Kassim, Adetola A.

“…•Multicenter learning collaborative model of haploidentical bone marrow transplantation (BMT) for sickle cell disease (SCD).•Using haploidentical BMT as…”
Get full text

Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemia by Gatwood, Katie S., Culos, Kathryn A., Binari, Laura A., Engelhardt, Brian G., Kassim, Adetola, Byrne, Michael T., Goodman, Stacey A., Chinratanalab, Wichai, Sengsayadeth, Salyka M., Greer, John P., Jagasia, Madan, Savani, Bipin N.

Get full text

American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group Survey on Chimeric Antigen Receptor T Cell Therapy Administrative, Logistic, and Toxicity Management Practices in the United States by Mahmoudjafari, Zahra, Hawks, Kelly G., Hsieh, Angela A., Plesca, Dragos, Gatwood, Katie S., Culos, Kathryn A.

“…•Immune effector cell (IEC) therapy is complex, with extensive coordination of healthcare teams.•This surveys explores administrative, logistic, and toxicity…”
Get full text

New‐onset posttransplant diabetes mellitus after haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide by Mangan, Brendan L., Patel, Dilan, Chen, Heidi, Gatwood, Katie S., Byrne, Michael T., Sengsayadeth, Salyka, Goodman, Stacey, Dholaria, Bhagirathbhai, Kassim, Adetola A., Jagasia, Madan, Chinratanalab, Wichai, Culos, Kathryn A., Engelhardt, Brian G.

“…Haploidentical hematopoietic cell transplantation (haplo‐HCT) with posttransplant cyclophosphamide (PTCY) is utilized for patients with hematological disorders…”
Get full text

Alternative agents to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections by Culos, Kathryn A, Cannon, Joan P, Grim, Shellee A

“…Resistant gram-positive infections, specifically methicillin-resistant Staphylococcus aureus (MRSA), carry an increased risk for morbidity and mortality…”
Get full text

Defining Incidence and Risk Factors for Catheter-Associated Bloodstream Infections in an Outpatient Adult Hematopoietic Cell Transplantation Program by McDonald, Marissa K., Culos, Kathryn A., Gatwood, Katie S., Prow, Caleb, Chen, Heidi, Savani, Bipin N., Byrne, Michael, Kassim, Adetola A., Engelhardt, Brian G., Jagasia, Madan, Satyanarayana, Gowri

“…•We report a 9% incidence of CLABSI in an outpatient hematopoietic transplant cohort.•Gram-positive cocci were implicated in the majority of CLABSIs.•Matched…”
Get full text

Ivosidenib: IDH1 Inhibitor for the Treatment of Acute Myeloid Leukemia by Merchant, Shelby L, Culos, Kathryn, Wyatt, Houston

“…There is no standard therapy for refractory acute myeloid leukemia (AML), but several salvage therapies are available (National Comprehensive Cancer Network…”
Get full text

Preparative Regimen Dosing for Hematopoietic Stem Cell Transplantation in Patients with Chronic Hepatic Impairment: Analysis of the Literature and Recommendations by Bodge, Megan N, Culos, Kathryn A, Haider, Syed Noman, Thompson, Michael Scott, Savani, Bipin N

“…Abstract Hematopoietic stem cell transplantation (HSCT) is a potentially life-saving therapy for patients with malignant and nonmalignant disease states…”
Get full text

Tacrolimus Metabolism and Risk of Acute Graft-Versus-Host-Disease by Krupski, M. Christa, DO, MPH, Bodiford, Andrew, PharmD, Culos, Kathryn, PharmD, BCOP, Kassim, Adetola A., MD, MS, Engelhardt, Brian G., MD, Greer, John, MD, Savani, Bipin N., MD, Chinratanalab, Wichai, Jagasia, Madan H., MD, MBBS, MS

Get full text

Chimeric Antigen Receptor T Cell Therapy: A Comprehensive Review of Clinical Efficacy, Toxicity, and Best Practices for Outpatient Administration by Alexander, Maurice, Culos, Kathryn, Roddy, Julianna, Shaw, J. Ryan, Bachmeier, Christina, Shigle, Terri Lynn, Mahmoudjafari, Zahra

“…Chimeric antigen receptor T cell (CAR T) therapy has been integrated into treatment algorithms for acute leukemia, lymphoma, and, most recently, multiple…”
Get full text

Characterizing Melphalan Efficacy and Toxicity in Multiple Myeloma Patients with Renal Insufficiency by Patel, Seema, PharmD, Culos, Kathryn, PharmD, Sweiss, Karen, PharmD, BCOP, Paul, Shilpa, PharmD, Patel, Pritesh Rajni, MD, Rondelli, Damiano, MD

Get full text

Reduction in Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Stem Cell Transplantation by Patel, Ameet, Wilkerson, Karina L, Culos, Kathryn A., Green, Jennifer, Byrne, Michael T., Sengsayadeth, Salyka M., Dholaria, Bhagirathbhai, Savani, Bipin N., Goodman, Stacey Ann, Chinratanalab, Wichai, Jayani, Reena, Gatwood, Katie S., Engelhardt, Brian G., Kassim, Adetola A.

“…Background: Venous thromboembolism (VTE) is a recognized complication of sickle cell disease (SCD). SCD confers a life-time risk of development of VTE, with a…”
Get full text

Reduced Insulin Sensitivity in Patients with Myeloid Malignancies and Clonal Hematopoiesis Mutations by Rao, Uttam K., Chen, Heidi, Gatwood, Katie S., Byrne, Michael T., Sengsayadeth, Salyka M., Goodman, Stacey A., Dholaria, Bhagirathbhai, Kassim, Adetola A., Savani, Bipin N., Chinratanalab, Wichai, Culos, Kathryn A., Savona, Michael R., Engelhardt, Brian G.

“…Cancer survivors are at increased risk for insulin resistance, which can lead to diabetes mellitus, dyslipidemia, and cardiovascular disease. Whether…”
Get full text

Increased Incidence of New-Onset Diabetes Mellitus Type II Following Haploidentical Bone Marrow Transplant with Post-Transplant Cyclophosphamide for Sickle Cell Disease by Patel, Dilan A, de la Fuente, Josu, Matheney, Michael, Karnik, Leena, Chen, Heidi, Gatwood, Katie S., Culos, Kathryn A., Wilkerson, Karina L, Byrne, Michael T., Sengsayadeth, Salyka M., Goodman, Stacey Ann, Dholaria, Bhagirathbhai, Savani, Bipin N., Chinratanalab, Wichai, Jayani, Reena, Connelly, Jim, Kitko, Carrie, Engelhardt, Brian G., Kassim, Adetola A.

“…Introduction: Haploidentical bone marrow transplant (haplo-BMT) with post-transplant cyclophosphamide (PTCy) provides near universal donor availability and…”
Get full text

Venetoclax-Based Salvage Therapy for Post-Hematopoietic Cell Transplantation Relapse in Acute Myeloid Leukemia by Byrne, Michael T, Danielson, Nathalie, Rasche, Adrianne, Hammers, Rachel, Culos, Kathryn A, Gatwood, Katie S, Wyatt, Houston, Fogo, Kristin, Dholaria, Bhagirathbhai, Engelhardt, Brian G, Ferrell, Paul Brent, Jagasia, Madan, Kassim, Adetola A., Mohan, Sanjay R, Savani, Bipin N., Strickland, Stephen A., Sengsayadeth, Salyka M., Savona, Michael R.

“…Introduction: AML pts who relapse after allogeneic hematopoietic cell transplantation (HCT) face poor clinical outcomes and short overall survival (OS) (Schmid…”
Get full text

Outcomes of Non-Myeloablative HLA-Haploidentical Bone Marrow Transplant with Thiotepa and Post-Transplant Cyclophosphamide in Children and Adults with Severe Sickle Cell Disease, a Phase II Trial: Vanderbilt Global Haploidentical Transplant Learning Collaborative (VGC2) by Kassim, Adetola A., de la Fuente, Josu, Alahmari, Ali Debsan, Eckrich, Michael J., Hanna, Rabi, Dhedin, Nathalie, Horn, Biljana N., Black, Vandy, Gouveia, Roseane V, Seber, Adriana, Simões, Belinda Pinto, Costa, Thalita Cristina de Mello, Guerino-Cunha, Renato, Bonfim, Carmem M.S., da Silva, Roberto Luiz, Hamerschlak, Nelson, Fernandes, Juliana Folloni, Kent, Michael, Yadav, Satya Prakash, Nur, Erfan, Alzahrani, Mohsen, Carpenter, Ben, Tse, William, Isabel, Maria, Rangarajan, Hemalatha G, Ahmed, Ibrahim, Akinsete, Adeseye Michael, Fitzhugh, Courtney D., Culos, Kathryn A., Karnik, Leena, Connelly, James, Kitko, Carrie, Andrews, Jennifer, Wilkerson, Karina L, Brodsky, Robert, Koyama, Tatsuki, DeBaun, Michael R.

“…Introduction: HLA-Haploidentical bone marrow transplant (haplo-BMT) is a curative approach for individuals with severe sickle cell disease (SCD) who lack an…”
Get full text

Outcomes of a Novel Rituximab-Based Non-Ablative Conditioning Regimen for Hematopoietic Cell Transplantation in Severe Aplastic Anemia by Gatwood, Katie S, Culos, Kathryn A, Binari, Laura A, Engelhardt, Brian G, Kassim, Adetola A., Byrne, Michael, Goodman, Stacey A, Chinratanalab, Wichai, Sengsayadeth, Salyka M., Greer, John P., Jagasia, Madan, Savani, Bipin N.

“…Introduction Older patients with severe aplastic anemia (SAA) needing hematopoietic cell transplantation (HCT) typically require utilization of reduced…”
Get full text